Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling
出版年份 2014 全文链接
标题
Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling
作者
关键词
Nucleotide analog, Tenofovir, Entecavir, Proximal renal tubular dysfunction, Kidney disease, Bone mineral density, Osteoporosis
出版物
DIGESTIVE DISEASES AND SCIENCES
Volume 60, Issue 2, Pages 566-572
出版商
Springer Nature
发表日期
2014-09-19
DOI
10.1007/s10620-014-3363-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Renal Function of Participants in the Bangkok Tenofovir Study--Thailand, 2005-2012
- (2014) M. Martin et al. CLINICAL INFECTIOUS DISEASES
- Tenofovir-associated Fanconi Syndrome in patients with chronic hepatitis B monoinfection
- (2013) David M Gracey et al. ANTIVIRAL THERAPY
- Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B
- (2013) Mauro Viganò et al. HEPATOLOGY
- Association of tenofovir exposure with kidney disease risk in HIV infection
- (2012) Rebecca Scherzer et al. AIDS
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
- (2012) Roger Bedimo et al. AIDS
- Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
- (2012) N. Gara et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
- (2012) Robert G. Gish et al. Clinical Gastroenterology and Hepatology
- Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine
- (2012) Hila Haskelberg et al. PLoS One
- Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
- (2011) Andrew M. Hall et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
- (2011) Stefan Mauss et al. JOURNAL OF HEPATOLOGY
- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
- (2011) Frédéric-Antoine Dauchy et al. KIDNEY INTERNATIONAL
- Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
- (2011) Albert Y. Liu et al. PLoS One
- High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study
- (2010) Anna Bonjoch et al. AIDS
- Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
- (2009) Pablo Labarga et al. AIDS
- Subclinical Tubular Injury in HIV-Infected Individuals on Antiretroviral Therapy: A Cross-sectional Analysis
- (2009) Andrew M. Hall et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Tenofovir-associated renal and bone toxicity
- (2009) CLN Woodward et al. HIV MEDICINE
- Bone Pain Due to Fractures Revealing Osteomalacia Related to Tenofovir-Induced Proximal Renal Tubular Dysfunction in a Human Immunodeficiency Virus-Infected Patient
- (2009) Serge Perrot et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started